The Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2008

Made12th November 2008

Laid before Parliament19th November 2008

Coming into force1st January 2009

The Secretary of State and the Minister of Health, Social Services and Public Safety, acting jointly, make the following Regulations in exercise of the powers conferred by sections 75(1), 76(1) and (2) and 129(1) and (5) of the Medicines Act 19681.

In the case of the Minister, the powers conferred by those provisions are now vested in the Minister2.

In accordance with section 129(6) of that Act, they have consulted such organisations as appear to them to be representative of interests likely to be substantially affected by the Regulations.

Citation and commencement1

These Regulations may be cited as the Medicines (Pharmacies) (Applications for Registration and Fees) Amendment Regulations 2008 and come into force on 1^st January 2009.

Amendment of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 19732

In regulation 3 (fees) of the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 19733—

a

in paragraph (1), for “£510” (fee for registration of premises, where premises are in Great Britain) substitute “£529”;

b

in paragraph (2), for “£162” (retention fee, where premises are in Great Britain) substitute “£168”; and

c

in paragraph (3), for “£510” (additional sum by way of penalty, where premises are in Great Britain) substitute “£529”.

Signed by authority of the Secretary of State for Health.

Phil HopeMinister of State,Department of Health8th November 2008

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety

Michael McGimpseyMinister of Health, Social Services and Public Safety12th November 2008

EXPLANATORY NOTE

(This note is not part of the Regulations)

These Regulations further amend the Medicines (Pharmacies) (Applications for Registration and Fees) Regulations 1973 as follows—

a

regulation 2(a) increases the fee for registration of premises at which a retail pharmacy business is, or is to be, carried on by 3.7% where the premises are in Great Britain;

b

regulation 2(b) increases the retention fee by 3.7% where the premises are in Great Britain; and

c

regulation 2(c) increases the penalty for failure to pay a retention fee (payable in the circumstances specified in section 76(2) of the Medicines Act 1968) by 3.7% where the premises are in Great Britain.

A full impact assessment of the effect that this instrument will have on the costs of businesses and the voluntary sector is available from the Department of Health, Skipton House, 80 London Road, London SE1 6LH.